Logo do repositório
 
Publicação

Multidrug efflux pumps in Staphylococcus aureus: an update.

dc.contributor.authorCosta, SS
dc.contributor.authorBettencourt, Miguel Viveiros
dc.contributor.authorAmaral, Leonard
dc.contributor.authorCouto, Isabel Maria dos Santos Leitão
dc.contributor.institutionInstituto de Higiene e Medicina Tropical (IHMT)
dc.contributor.institutionCREM - Centro de Recursos Microbiológicos
dc.contributor.pblBentham Open
dc.date.accessioned2021-05-04T22:31:14Z
dc.date.available2021-05-04T22:31:14Z
dc.date.issued2013-01-01
dc.description.abstractThe emergence of infections caused by multi- or pan-resistant bacteria in the hospital or in the community settings is an increasing health concern. Albeit there is no single resistance mechanism behind multiresistance, multidrug efflux pumps, proteins that cells use to detoxify from noxious compounds, seem to play a key role in the emergence of these multidrug resistant (MDR) bacteria. During the last decades, experimental data has established their contribution to low level resistance to antimicrobials in bacteria and their potential role in the appearance of MDR phenotypes, by the extrusion of multiple, unrelated compounds. Recent studies suggest that efflux pumps may be used by the cell as a first-line defense mechanism, avoiding the drug to reach lethal concentrations, until a stable, more efficient alteration occurs, that allows survival in the presence of that agent. In this paper we review the current knowledge on MDR efflux pumps and their intricate regulatory network in Staphylococcus aureus, a major pathogen, responsible from mild to life-threatening infections. Particular emphasis will be given to the potential role that S. aureus MDR efflux pumps, either chromosomal or plasmid-encoded, have on resistance towards different antimicrobial agents and on the selection of drug - resistant strains. We will also discuss the many questions that still remain on the role of each specific efflux pump and the need to establish appropriate methodological approaches to address all these questions.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent164473
dc.identifier.doi10.2174/1874285801307010059
dc.identifier.issn1874-2858
dc.identifier.otherPURE: 157905
dc.identifier.otherPURE UUID: 04af8331-c342-4bdb-8dde-3966a927d2bc
dc.identifier.otherresearchoutputwizard: 44119
dc.identifier.otherPubMed: 23569469
dc.identifier.otherScopus: 84876097865
dc.identifier.otherORCID: /0000-0001-9676-6251/work/45270479
dc.identifier.otherORCID: /0000-0003-3536-2733/work/51474512
dc.identifier.otherORCID: /0000-0002-4096-2410/work/48780763
dc.identifier.urihttp://hdl.handle.net/10362/116937
dc.language.isoeng
dc.peerreviewedyes
dc.subjectBiochemistry, Genetics and Molecular Biology (miscellaneous)
dc.subjectInfectious Diseases
dc.subjectSDG 3 - Good Health and Well-being
dc.titleMultidrug efflux pumps in Staphylococcus aureus: an update.en
dc.typejournal article
degois.publication.firstPage59
degois.publication.issueSuppl 1-M5
degois.publication.lastPage71
degois.publication.titleOpen Microbiology Journal
degois.publication.volume7
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Multidrug_Efflux_Pumps_in_Staphylococcus_aureus.pdf
Tamanho:
160.62 KB
Formato:
Adobe Portable Document Format